Skip to main content

National Vision Holdings, Inc. Reports Third Quarter 2026 Financial Results

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Strong Execution Drives Significant Margin Expansion and More Than Doubles Adjusted EPS

New Store Growth Expected to Accelerate in 2027, One Year Ahead of Plan

Updates Fiscal 2026 Outlook

Third quarter 2026 highlights compared to third quarter 2025:

  • Net revenue of $510.5 million, increased 4.8%
  • Comparable store sales growth of 3.6% and Adjusted Comparable Store Sales Growth of 2.8%
  • Net income of $19.2 million, Diluted EPS of $0.24, with Net income margin improving to 3.8% from 0.7%
  • Adjusted Operating Income increased to $37.1 million from $19.8 million, with Adjusted Operating Margin expanding 320 basis points to 7.3% from 4.1%
  • Excluding the one-time benefit of IEEPA tariff refunds of $4.7 million, Adjusted Operating Income increased to $32.4 million from $19.8 million, with Adjusted Operating Margin expanding 230 basis points to 6.4% from 4.1%
  • Adjusted Diluted EPS increased to $0.30 from $0.13

National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision,” “we,” “our,” “us” or the “Company”) today reported its financial results for the third quarter ended October 3, 2026.

“Our strategy continues to deliver profitable growth as we execute the commercial transformation of the business,” said Alex Wilkes, National Vision’s CEO. “Third quarter adjusted operating margin expanded 320 basis points and adjusted diluted earnings per share more than doubled year over year. Comparable store sales growth was bolstered by positive traffic and ticket in our managed care cohort that meaningfully contributed to our profitability. Growth in higher value transactions offset industry headwinds concentrated in lower-value transactions. These lower value transactions represent only a high single digit share of sales and an even smaller share of gross profit – a distinction that matters as we focus on growth that translates into stronger earnings.”

Mr. Wilkes continued, “Our strong earnings power and cash flow generation gives us the flexibility to accelerate our new store openings one year ahead of plan while continuing to invest in the capabilities that will strengthen National Vision over the long term. We are updating our outlook to reflect the current consumer environment, and through continued disciplined execution, we expect to deliver full year profitability in line with our long-term algorithm. We believe the actions we are taking are building a stronger, more durable business, positioning National Vision to gain share and deliver durable profitable growth.”

This release includes certain Non-GAAP Financial Measures that are not recognized under generally accepted accounting principles (“GAAP”), including Adjusted Comparable Store Sales Growth, Adjusted Operating Income, Adjusted Operating Margin, Adjusted SG&A and Adjusted Diluted EPS. Please see “Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP to GAAP Financial Measures” below for more information.

Third Quarter 2026 Summary

  • Net revenue increased 4.8% to $510.5 million driven by Adjusted Comparable Store Sales Growth, new store sales, partially offset by closed stores and a negative 0.8% impact from the timing of unearned revenue.
  • Comparable store sales growth was 3.6% and Adjusted Comparable Store Sales Growth was 2.8%, driven by higher average ticket that primarily reflects a favorable mix shift toward higher-value products, and continued strength in the managed care cohort, partially offset by lower self-pay customer traffic.
  • The Company opened eight new America’s Best stores and closed three America’s Best stores and one Eyeglass World store, ending the quarter with 1,285 stores. Overall, store count grew 3.5%.
  • Costs applicable to revenue increased 3.4% to $210.1 million. As a percentage of net revenue, costs applicable to revenue decreased 60 basis points to 41.1%, reflecting a one-time benefit of IEEPA tariff refunds of $4.7 million and leverage of optometrist-related costs on higher exam revenue, partially offset by lower product margin rate resulting from a strategic mix shift toward higher-value product offerings.
  • Excluding the one-time benefit of IEEPA tariff refunds, costs applicable to revenue as a percentage of net revenue increased 40 basis points, reflecting higher-value product mix of goods sold that generate higher gross profit dollars despite lower product margin rates.
  • Selling, general and administrative expenses (SG&A) decreased 2.1% to $247.1 million. As a percentage of net revenue, SG&A decreased 340 basis points to 48.4%, primarily driven by improved store labor efficiency, lower variable incentive compensation, as well as continued execution of cost optimization efforts. Adjusted SG&A decreased 0.5% to $241.2 million and represented 47.2% of net revenue, a decrease of 250 basis points.
  • Net income increased to $19.2 million, compared to $3.4 million in the prior-year period. Net income margin improved to 3.8% from 0.7%.
  • Diluted earnings per share (EPS) increased to $0.24 compared to $0.04. Adjusted Diluted EPS increased to $0.30 from $0.13. The net change in margin on unearned revenue negatively impacted both Diluted EPS and Adjusted Diluted EPS by $(0.03).
  • Adjusted Operating Income increased 87.4% to $37.1 million. Adjusted Operating Margin improved 320 basis points to 7.3% from 4.1%. The net change in margin on unearned revenue negatively impacted net income by $2.2 million and Adjusted Operating Income by $2.9 million.

Year-to-Date 2026 Summary

  • Net revenue increased 4.7% to $1,553.2 million driven by Adjusted Comparable Store Sales Growth, new store sales, and a positive 0.7% impact from the timing of unearned revenue, partially offset by closed stores.
  • Comparable store sales growth was 3.8% and Adjusted Comparable Store Sales Growth was 3.2%, primarily due to higher average ticket that primarily reflects a favorable mix shift toward higher-value products, and continued strength in the managed care cohort, partially offset by lower self-pay customer traffic.
  • The Company opened 25 new America’s Best stores and closed eight America’s Best stores, one Military store and one Eyeglass World store. Additionally, the Company expanded its presence in the military channel by adding 20 new Military stores. Total store count at the end of the period was 1,285 stores, and overall, store count grew 3.5%.
  • Costs applicable to revenue increased 4.7% to $637.6 million. As a percentage of net revenue, costs applicable to revenue remained flat at 41.0%, reflecting a one-time benefit of IEEPA tariff refunds of $4.7 million, offset by a strategic mix shift toward higher-value product offerings.
  • Excluding the one-time benefit of IEEPA tariff refunds, costs applicable to revenue as a percentage of net revenue increased 30 basis points, reflecting higher-value product mix of goods sold that generate higher gross profit dollars despite lower product margin rates.
  • Selling, general and administrative expenses (SG&A) decreased 1.1% to $746.7 million. As a percentage of net revenue, SG&A decreased 280 basis points to 48.1% primarily driven by improved store labor efficiency, lower variable incentive compensation, as well as lower advertising and promotional spending. Adjusted SG&A remained flat at $723.4 million and decreased 210 basis points to 46.6% of net revenue.
  • Net income increased to $62.8 million compared to $26.3 million. Net income margin increased to 4.0% compared to 1.8%.
  • Diluted EPS increased to $0.78 compared to $0.33. Adjusted Diluted EPS increased to $1.01 compared to $0.65. The net change in margin on unearned revenue benefited both Diluted EPS and Adjusted Diluted EPS by $0.07.
  • Adjusted Operating Income increased 46.3% to $124.2 million. Adjusted Operating Margin expanded 230 basis points to 8.0% compared to 5.7%. The net change in margin on unearned revenue benefited net income by $5.3 million and Adjusted Operating Income by $7.1 million.

Balance Sheet and Cash Flow Highlights as of October 3, 2026

  • National Vision’s cash balance was $60.0 million as of October 3, 2026. The Company had no borrowings outstanding under its $300.0 million first lien revolving credit facility, exclusive of letters of credit of $6.7 million.
  • Total debt was $233.6 million as of October 3, 2026, consisting of outstanding first lien term loans and finance lease obligations, net of unamortized discounts.
  • During the three months ended October 3, 2026, the Company repurchased approximately 1.1 million shares for $20.0 million. As of October 3, 2026, the share repurchase authorization had remaining capacity of $10.0 million.

Share Repurchase Program

Effective November 9, 2026, the Company's board of directors authorized the Company to repurchase up to $100 million aggregate amount of shares of the Company's common stock until December 28, 2030. The new share repurchase authorization replaces the Company's previous share repurchase authorization approved effective March 2, 2026, which had remaining capacity of $10.0 million at the time of its replacement. Repurchases of shares of common stock may be made through various methods, including, but not limited to, open market, privately negotiated, or accelerated share repurchase transactions. The timing, manner, price, and actual amount of share repurchases will be determined by management based on various factors, including, but not limited to, stock price, economic and market conditions, other capital management needs and opportunities, and corporate and regulatory considerations. The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be suspended or discontinued at any time.

Fiscal 2026 Outlook

The Company is updating its fiscal 2026 outlook for the 52 weeks ending January 2, 2027, as set forth below.

 

Prior Fiscal 2026 Outlook

(As of August 12, 2026)

Updated Fiscal 2026 Outlook

(As of November 12, 2026)

New Stores(1)

30-35

~30

Adjusted Comparable Store Sales Growth(2)

3.0% - 5.0%

2.0% - 3.0%

Net Revenue

$2.037 billion - $2.076 billion

$2.019 billion - $2.038 billion

Adjusted Operating Income(2)

$119 million - $139 million

$119 million - $131 million

Adjusted Diluted EPS(2)(3)

$0.94 - $1.09

$0.95 - $1.03

Depreciation and Amortization(4)

$92 million - $93 million

$92 million - $93 million

Interest(5)

$11 million - $13 million

$11 million - $13 million

Tax Rate(6)

~30%

~30%

Capital Expenditures

$72 million - $76 million

$72 million - $74 million

1

Assumes primarily America's Best new stores, does not include 20 Military store additions in April 2026.

2

Refer to “Non-GAAP Financial Measures” below for more information.

3

Assumes approximately 81 million shares.

4

Includes amortization of acquisition intangibles of approximately $0.7 million, which is excluded in the definition of Adjusted Operating Income.

5

Before the impact of gains or losses on change in fair value of derivatives and charges related to debt discounts and deferred financing costs.

6

Excluding the impact of vesting of restricted stock units and stock option exercises.

The fiscal 2026 outlook information provided in this release includes Adjusted Operating Income and Adjusted Diluted EPS guidance. The Company is not able to reconcile these forward-looking non-GAAP measures to GAAP without unreasonable efforts because it is not possible to predict with a reasonable degree of certainty the actual impact of certain items and unanticipated events, including taxes and non-recurring items, which would be included in GAAP results.

The fiscal 2026 outlook is forward-looking, subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the control of the Company and its management, and based upon assumptions with respect to future decisions, which are subject to change. These uncertainties include, but are not limited to, dynamic market conditions, unexpected disruptions including additional regulatory actions impacting international trade such as tariffs, issues relating to the implementation of our transformation initiatives, geopolitical issues, higher transportation or other costs due to rising fuel or energy costs, and other macroeconomic risks and uncertainties. Actual results may vary and those variations may be material. As such, the Company’s results may not fall within the ranges contained in its fiscal 2026 outlook. The Company uses these forward-looking measures internally to assess and benchmark its results and strategic plans. See “Forward-Looking Statements” below.

Conference Call Details

The Company will host a conference call to discuss the third quarter 2026 financial results and fiscal-year 2026 guidance today, November 12, 2026, at 8:30 a.m. Eastern Time. To pre-register for the conference call and obtain a dial-in number and passcode, please refer to the “Investors” section of the Company’s website at www.ir.nationalvision.com. A live audio webcast of the conference call will be available on the “Investors” section of the Company’s website at www.ir.nationalvision.com, where presentation materials will be posted prior to the conference call. A replay of the audio webcast will also be archived on the “Investors” section of the Company’s website.

About National Vision Holdings, Inc.

National Vision Holdings, Inc. (NASDAQ: EYE) is one of the largest optical retail companies in the United States with over 1,200 stores in 40 states and Puerto Rico. With a mission of helping people by making quality eye care and eyewear more affordable and accessible, the company operates four retail brands: America’s Best Contacts & Eyeglasses, Eyeglass World, and Vista Opticals inside select Fred Meyer stores and on select military bases, and an e-commerce website DiscountContacts.com, offering a variety of products and services for customers’ eye care needs. For more information, please visit www.nationalvision.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, statements contained under “Fiscal 2026 Outlook,” as well as other statements related to our current beliefs and expectations regarding the performance of our industry, the Company’s strategic direction, market position, prospects including remote medicine and optometrist recruiting and retention initiatives, and future results. You can identify these forward-looking statements by the use of words such as “outlook,” “guidance,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or variations of these words or other comparable words. Caution should be taken not to place undue reliance on any forward-looking statement as such statements speak only as of the date when made. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. Forward-looking statements are not guarantees and are subject to various risks and uncertainties, which may cause actual results to differ materially from those implied in forward-looking statements. Such factors include, but are not limited to, market volatility, an overall decline in the health of the economy, global macroeconomic conditions and other factors that may affect consumer spending or behavior; our ability to successfully implement our strategic initiatives, or anticipate the impact of important strategic initiatives; our ability to recruit and retain vision care professionals for in-store roles or to provide remote care offerings; our ability to compete in the highly competitive optical retail industry; our ability to maintain, protect, and enhance the value of our owned brands; the success of our marketing, advertising and promotional efforts; our ability to open and operate new stores (including as a result of store conversions) in a timely and cost-effective manner or to successfully enter new markets; our ability to increase sales in existing stores and to successfully reinvest in existing stores; our ability to successfully implement our pricing strategies; changes in the cost of inputs, and factors such as wage rate increases, inflation, cost increases, tariffs and related measures, increases in the price of raw materials and energy prices; significant capital requirements to fund our expanding business including updating our Enterprise Resource Planning (“ERP”) and Customer Relationship Management (“CRM”), and other technological, systems and capabilities; the potential for our growth strategies to strain our existing resources and cause the performance of our existing stores to suffer; risks associated with leasing substantial amounts of space, including future increases in occupancy costs; our ability to successfully manage the distinct risks faced by our e-commerce and omni-channel business; our ability to retain our existing senior management team, attract qualified new personnel or successfully implement our succession plans; seasonal fluctuations in our operating results and inventory levels; the potential impacts of catastrophic events, including changing climate and weather patterns leading to severe weather and natural disasters; the potential for certain technological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, or future drug development for the correction of vision-related problems to reduce the demand for our products; our ability to successfully manage our inventory balances and inventory shrinkage; the potential for the loss of, or disruption in the operations of, one or more of our distribution centers or optical laboratories, which would impact our ability to process and fulfill customer orders and deliver our products in a timely manner, or at all, or result in quality issues; the performance of our Host brands and our ability to maintain or extend our operating relationships with our Host partners; sustainability issues, including those related to climate change; our ability to develop, maintain and extend relationships with managed vision care companies, vision insurance providers and other third-party payors; our reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of our revenues; risks associated with vendors from whom our products and certain services are sourced and our dependence on a limited number of suppliers; changes in U.S. or international laws, including tariffs, affecting our ability to source merchandise and services internationally; the impact of any significant failure, inadequacy, interruption or security breach affecting our information technology systems, or those of our vendors; our ability to comply with state, local and federal vision care and healthcare laws and regulations, as well as managed vision care laws and regulations; liability stemming from rapidly changing and increasingly stringent laws, regulations, contractual obligations, and industry standards relating to privacy, data security and data protection; product liability, product recall or personal injury issues; our ability to comply with laws, regulations and enforcement activities or changes in statutory, regulatory, accounting and other legal requirements; the outcome of legal proceedings relating to our business operations; the protection and validity of our intellectual property; risks related to our indebtedness; changes in interest rates; restrictions in our credit agreement that limit our flexibility in operating our business; and risks related to owning our common stock. Additional information about these and other factors that could cause National Vision’s results to differ materially from those described in the forward-looking statements can be found in filings by National Vision with the Securities and Exchange Commission (“SEC”), including our latest Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC.

Non-GAAP Financial Measures

To supplement the Company’s financial information presented in accordance with GAAP and aid understanding of the Company’s business performance, the Company uses certain non-GAAP financial measures, namely “EBITDA,” “Adjusted Operating Income,” “Adjusted Operating Margin,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Diluted EPS,” “Adjusted Comparable Store Sales Growth,” “Adjusted SG&A,” and “Adjusted SG&A Percent of Net Revenue.” We believe EBITDA, Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, Adjusted SG&A, and Adjusted SG&A Percent of Net Revenue assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses these non-GAAP financial measures to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone.

To supplement the Company’s comparable store sales growth presented in accordance with GAAP, the Company provides “Adjusted Comparable Store Sales Growth,” which is a non-GAAP financial measure we believe is useful because it provides timely and accurate information relating to the two core metrics of retail sales: number of transactions and value of transactions. Management uses Adjusted Comparable Store Sales Growth as the basis for key operating decisions, such as allocation of advertising to particular markets and implementation of special marketing programs. Accordingly, we believe that Adjusted Comparable Store Sales Growth provides timely and accurate information relating to the operational health and overall performance of each brand. We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Store Sales Growth to be meaningful.

EBITDA: We define EBITDA as net income (loss), plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization.

Adjusted Operating Income: We define Adjusted Operating Income as net income (loss), plus interest expense (income), net and income tax provision (benefit), further adjusted to exclude stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, Enterprise Resource Planning (“ERP”) and Customer Relationship Management (“CRM”) implementation expenses, shareholder activism costs, severance and associate-related costs associated with organizational restructuring and certain other expenses.

Adjusted Operating Margin: We define Adjusted Operating Margin as Adjusted Operating Income as a percentage of net revenue.

Adjusted EBITDA: We define Adjusted EBITDA as net income (loss), plus interest expense (income), net, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, ERP and CRM implementation expenses, shareholder activism costs, severance and associate-related costs associated with organizational restructuring and certain other expenses.

Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue.

Adjusted Diluted EPS: We define Adjusted Diluted EPS as diluted earnings (loss) per share, adjusted for the per share impact of stock-based compensation expense, (gain) loss on extinguishment of debt, asset impairment, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expenses, amortization of debt discounts and deferred financing costs of our term loan borrowings, amortization of the conversion feature and deferred financing costs related to our 2.50% convertible senior notes due on May 15, 2025 ("2025 Notes") when not required under U.S. GAAP to be added back for diluted earnings (loss) per share, derivative fair value adjustments, ERP and CRM implementation expenses, shareholder activism, severance and associate-related costs associated with restructuring and certain other expenses, less the tax effect of these adjustments, including tax expense (benefit) from stock-based compensation.

Adjusted SG&A: We define Adjusted SG&A as SG&A adjusted to exclude stock-based compensation expense, litigation settlement, secondary offering expenses, management realignment expenses, long-term incentive plan expense, ERP and CRM implementation expenses, shareholder activism, severance and employee-related costs associated with restructuring and certain other expenses.

Adjusted SG&A Percent of Net Revenue: We define Adjusted SG&A Percent of Net Revenue as Adjusted SG&A as a percentage of total net revenue.

Adjusted Comparable Store Sales Growth: We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows: (i) sales are recorded at the point of sale (ii) sales are adjusted for managed care insurance collection estimates (iii) stores are added to the calculation during the 13th full fiscal month following the store’s opening; (iv) closed stores are removed from the calculation for time periods that are not comparable; (v) sales from partial months of operation are excluded when stores do not open or close on the first day of the month; and (vi) when applicable, we adjust for the effect of the 53rd week; (vii) in fiscal years following a 53-week fiscal year, there is a one week calendar shift to the comparable prior year period. For the calculation of the adjusted comparable store sales growth in the three months ended October 3, 2026, we compared weeks 27 through 39 in fiscal 2026 against weeks 28 through 40 in fiscal 2025 and for the nine months ended October 3, 2026, we compared weeks 1 through 39 in fiscal year 2026 against weeks 2 through 40 in fiscal year 2025. Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period. When a partial month is excluded from the calculation, the corresponding month in the subsequent period is also excluded from the calculation. There may be variations in the way in which some of our competitors and other retailers calculate comparable store sales. As a result, our adjusted comparable store sales may not be comparable to similar data made available by other retailers.

EBITDA, Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, Adjusted SG&A, Adjusted SG&A Percent of Net Revenue and Adjusted Comparable Store Sales Growth are not recognized terms under U.S. GAAP and should not be considered as an alternative to net income or income from operations as a measure of financial performance, SG&A, the ratio of SG&A to net revenue as a measure of financial performance, cash flows provided by operating activities as a measure of liquidity, comparable store sales growth as a measure of operating performance, or any other performance measure derived in accordance with U.S. GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use as they do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.

Please see “Reconciliation of Non-GAAP to GAAP Financial Measures” below for reconciliations of non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures.

National Vision Holdings, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

 

In thousands, except share data

As of

October 3, 2026

 

As of

January 3, 2026

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

59,963

 

 

$

38,708

 

Accounts receivable, net

 

40,982

 

 

 

57,322

 

Inventories, net

 

123,783

 

 

 

89,318

 

Prepaid expenses and other current assets

 

31,507

 

 

 

40,374

 

Total current assets

 

256,235

 

 

 

225,722

 

 

 

 

 

Noncurrent assets:

 

 

 

Property and equipment, net

 

327,412

 

 

 

344,619

 

Goodwill

 

700,976

 

 

 

700,642

 

Trademarks and trade names

 

240,547

 

 

 

240,547

 

Other intangible assets, net

 

7,047

 

 

 

7,554

 

Right of use assets

 

401,151

 

 

 

394,896

 

Other assets

 

70,208

 

 

 

69,698

 

Total noncurrent assets

 

1,747,341

 

 

 

1,757,956

 

Total assets

$

2,003,576

 

 

$

1,983,678

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

75,992

 

 

$

78,999

 

Other payables and accrued expenses

 

110,108

 

 

 

109,674

 

Unearned revenue

 

45,783

 

 

 

52,279

 

Deferred revenue

 

64,270

 

 

 

64,560

 

Current maturities of long-term debt and finance lease obligations

 

16,276

 

 

 

16,583

 

Current operating lease obligations

 

93,276

 

 

 

90,313

 

Total current liabilities

 

405,705

 

 

 

412,408

 

 

 

 

 

Noncurrent liabilities:

 

 

 

Long-term debt and finance lease obligations, less current portion and debt issuance costs

 

217,360

 

 

 

229,327

 

Noncurrent operating lease obligations

 

361,135

 

 

 

358,377

 

Deferred revenue

 

22,640

 

 

 

22,517

 

Other liabilities

 

8,734

 

 

 

8,944

 

Deferred income taxes, net

 

86,828

 

 

 

82,572

 

Total noncurrent liabilities

 

696,697

 

 

 

701,737

 

Commitments and contingencies

 

 

 

Stockholders’ equity:

 

 

 

Common stock, $0.01 par value; 200,000,000 shares authorized; 87,629,000 and 86,278,538 shares issued as of October 3, 2026 and January 3, 2026, respectively; 78,066,064 and 79,416,050 shares outstanding as of October 3, 2026 and January 3, 2026, respectively

 

876

 

 

 

862

 

Additional paid-in capital

 

854,320

 

 

 

834,000

 

Accumulated other comprehensive income (loss)

 

379

 

 

 

(121

)

Retained earnings

 

318,502

 

 

 

255,717

 

Treasury stock, at cost; 9,562,936 and 6,862,488 shares as of October 3, 2026 and January 3, 2026, respectively

 

(272,903

)

 

 

(220,925

)

Total stockholders’ equity

 

901,174

 

 

 

869,533

 

Total liabilities and stockholders’ equity

$

2,003,576

 

 

$

1,983,678

 

National Vision Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations and Comprehensive Income (Unaudited)

 

 

Three Months Ended

 

Nine Months Ended

In thousands, except per share amounts

October 3, 2026

 

September 27, 2025

 

October 3, 2026

 

September 27, 2025

Revenue:

 

 

 

 

 

 

 

Net product sales

$

410,609

 

 

$

393,483

 

 

$

1,253,244

 

 

$

1,200,837

 

Net sales of services and plans

 

99,924

 

 

 

93,847

 

 

 

299,974

 

 

 

283,240

 

Total net revenue

 

510,533

 

 

 

487,330

 

 

 

1,553,218

 

 

 

1,484,077

 

Costs applicable to revenue (exclusive of depreciation and amortization):

 

 

 

 

 

 

 

Products

 

116,858

 

 

 

114,615

 

 

 

362,249

 

 

 

346,215

 

Services and plans

 

93,204

 

 

 

88,584

 

 

 

275,321

 

 

 

262,545

 

Total costs applicable to revenue

 

210,062

 

 

 

203,199

 

 

 

637,570

 

 

 

608,760

 

Operating expenses:

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

247,134

 

 

 

252,339

 

 

 

746,658

 

 

 

755,038

 

Depreciation and amortization

 

22,646

 

 

 

22,185

 

 

 

69,309

 

 

 

67,684

 

Asset impairment

 

—

 

 

 

—

 

 

 

2,506

 

 

 

502

 

Other income, net

 

(301

)

 

 

(1

)

 

 

(358

)

 

 

(101

)

Total operating expenses

 

269,479

 

 

 

274,523

 

 

 

818,115

 

 

 

823,123

 

Income from operations

 

30,992

 

 

 

9,608

 

 

 

97,533

 

 

 

52,194

 

Interest expense, net

 

2,992

 

 

 

4,119

 

 

 

9,177

 

 

 

12,901

 

Earnings before income taxes

 

28,000

 

 

 

5,489

 

 

 

88,356

 

 

 

39,293

 

Income tax provision

 

8,812

 

 

 

2,117

 

 

 

25,571

 

 

 

13,010

 

Net income

$

19,188

 

 

$

3,372

 

 

$

62,785

 

 

$

26,283

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

0.24

 

 

$

0.04

 

 

$

0.79

 

 

$

0.33

 

Diluted

$

0.24

 

 

$

0.04

 

 

$

0.78

 

 

$

0.33

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic

 

78,698

 

 

 

79,223

 

 

 

79,300

 

 

 

79,053

 

Diluted

 

80,064

 

 

 

81,195

 

 

 

80,718

 

 

 

80,170

 

 

 

 

 

 

 

 

 

Comprehensive income:

 

 

 

 

 

 

 

Net income

$

19,188

 

 

$

3,372

 

 

$

62,785

 

 

$

26,283

 

Unrealized gain on hedge instruments

 

74

 

 

 

—

 

 

 

667

 

 

 

—

 

Tax provision of unrealized gain on hedge instruments

 

18

 

 

 

—

 

 

 

167

 

 

 

—

 

Comprehensive income

$

19,244

 

 

$

3,372

 

 

$

63,285

 

 

$

26,283

 

National Vision Holdings, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

 

 

Nine Months Ended

In Thousands

October 3, 2026

 

September 27, 2025

Cash flows from operating activities:

 

 

 

Net income

$

62,785

 

 

$

26,283

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

 

69,309

 

 

 

67,684

 

Amortization of debt issuance costs

 

725

 

 

 

932

 

Amortization of cloud computing implementation costs

 

9,951

 

 

 

6,823

 

Asset impairment

 

2,506

 

 

 

502

 

Deferred income tax expense (benefit)

 

4,256

 

 

 

(879

)

Stock-based compensation expense

 

19,301

 

 

 

17,836

 

Inventory adjustments

 

4,361

 

 

 

3,818

 

Other

 

489

 

 

 

(334

)

Changes in operating assets and liabilities:

 

 

 

Accounts receivable

 

16,248

 

 

 

2,974

 

Inventories

 

(38,826

)

 

 

2,088

 

Operating lease right of use assets and lease liabilities

 

149

 

 

 

(2,249

)

Other assets

 

(7,636

)

 

 

(26,077

)

Accounts payable

 

(3,007

)

 

 

20,621

 

Deferred and unearned revenue

 

(6,663

)

 

 

7,686

 

Other liabilities

 

925

 

 

 

5,426

 

Net cash provided by operating activities

 

134,873

 

 

 

133,134

 

Cash flows from investing activities:

 

 

 

Purchase of property and equipment

 

(55,481

)

 

 

(48,441

)

Other

 

5,006

 

 

 

(3,848

)

Net cash used for investing activities

 

(50,475

)

 

 

(52,289

)

Cash flows from financing activities:

 

 

 

Repayments on long-term debt

 

(19,937

)

 

 

(94,712

)

Borrowings on long-term debt

 

10,000

 

 

 

—

 

Payments on finance lease obligations

 

(2,485

)

 

 

(2,255

)

Proceeds from issuance of common stock

 

1,110

 

 

 

1,013

 

Purchase of treasury stock

 

(51,998

)

 

 

(2,555

)

Net cash used for financing activities

 

(63,310

)

 

 

(98,509

)

Net change in cash, cash equivalents and restricted cash

 

21,088

 

 

 

(17,664

)

Cash, cash equivalents and restricted cash, beginning of year

 

40,302

 

 

 

75,237

 

Cash, cash equivalents and restricted cash, end of period (i)

$

61,390

 

 

$

57,573

 

(i) Cash balance includes restricted cash of $1.4 million and $1.5 million for the nine months ended October 3, 2026 and September 27, 2025, respectively, that are not reflected in cash and cash equivalents shown on the Condensed Consolidated Balance Sheets.

National Vision Holdings, Inc. and Subsidiaries

Reconciliation of Non-GAAP to GAAP Financial Measures (Unaudited)

Reconciliation of Adjusted Operating Income to Net Income

 

Three Months Ended

 

Nine Months Ended

In thousands

October 3, 2026

 

September 27, 2025

 

October 3, 2026

 

September 27, 2025

Net income

$

19,188

 

 

$

3,372

 

 

$

62,785

 

 

$

26,283

 

Interest expense, net

 

2,992

 

 

 

4,119

 

 

 

9,177

 

 

 

12,901

 

Income tax provision

 

8,812

 

 

 

2,117

 

 

 

25,571

 

 

 

13,010

 

Stock-based compensation expense (a)

 

5,913

 

 

 

5,501

 

 

 

19,301

 

 

 

17,836

 

Asset impairment (b)

 

—

 

 

 

—

 

 

 

2,506

 

 

 

502

 

Litigation settlement (c)

 

—

 

 

 

1,903

 

 

 

—

 

 

 

1,903

 

Amortization of acquisition intangibles (d)

 

169

 

 

 

169

 

 

 

507

 

 

 

507

 

ERP and CRM implementation expenses (f)

 

336

 

 

 

1,368

 

 

 

1,262

 

 

 

5,529

 

Other (g)

 

(285

)

 

 

1,258

 

 

 

3,050

 

 

 

6,412

 

Adjusted Operating Income

$

37,125

 

 

$

19,807

 

 

$

124,159

 

 

$

84,883

 

 

 

 

 

 

 

 

 

Net income margin

 

3.8

%

 

 

0.7

%

 

 

4.0

%

 

 

1.8

%

Adjusted Operating Margin

 

7.3

%

 

 

4.1

%

 

 

8.0

%

 

 

5.7

%

 

 

 

 

 

 

 

 

Note: Percentages reflect line item as a percentage of total net revenue, adjusted for rounding.

Reconciliation of EBITDA and Adjusted EBITDA to Net Income

 

Three Months Ended

 

Nine Months Ended

In thousands

October 3, 2026

 

September 27, 2025

 

October 3, 2026

 

September 27, 2025

Net income

$

19,188

 

 

$

3,372

 

 

$

62,785

 

 

$

26,283

 

Interest expense, net

 

2,992

 

 

 

4,119

 

 

 

9,177

 

 

 

12,901

 

Income tax provision

 

8,812

 

 

 

2,117

 

 

 

25,571

 

 

 

13,010

 

Depreciation and amortization

 

22,646

 

 

 

22,185

 

 

 

69,309

 

 

 

67,684

 

EBITDA

 

53,638

 

 

 

31,793

 

 

 

166,842

 

 

 

119,878

 

 

 

 

 

 

 

 

 

Stock-based compensation expense (a)

 

5,913

 

 

 

5,501

 

 

 

19,301

 

 

 

17,836

 

Asset impairment (b)

 

—

 

 

 

—

 

 

 

2,506

 

 

 

502

 

Litigation settlement (c)

 

—

 

 

 

1,903

 

 

 

—

 

 

 

1,903

 

ERP and CRM implementation expenses (f)

 

336

 

 

 

1,368

 

 

 

1,262

 

 

 

5,529

 

Other (g)

 

(285

)

 

 

1,258

 

 

 

3,050

 

 

 

6,412

 

Adjusted EBITDA

$

59,602

 

 

$

41,823

 

 

$

192,961

 

 

$

152,060

 

 

 

 

 

 

 

 

 

Net income margin

 

3.8

%

 

 

0.7

%

 

 

4.0

%

 

 

1.8

%

Adjusted EBITDA Margin

 

11.7

%

 

 

8.6

%

 

 

12.4

%

 

 

10.2

%

 

 

 

 

 

 

 

 

Note: Percentages reflect line item as a percentage of total net revenue, adjusted for rounding.

Reconciliation of Adjusted Diluted EPS to Diluted EPS

 

Three Months Ended

 

Nine Months Ended

Shares in thousands, except per share amounts

October 3, 2026

 

September 27, 2025

 

October 3, 2026

 

September 27, 2025

Diluted EPS

$

0.24

 

 

$

0.04

 

 

$

0.78

 

 

$

0.33

 

Stock-based compensation expense (a)

 

0.07

 

 

 

0.07

 

 

 

0.24

 

 

 

0.22

 

Asset impairment (b)

 

—

 

 

 

—

 

 

 

0.03

 

 

 

0.01

 

Litigation settlement (c)

 

—

 

 

 

0.02

 

 

 

—

 

 

 

0.02

 

Amortization of acquisition intangibles (d)

 

—

 

 

 

—

 

 

 

0.01

 

 

 

0.01

 

Amortization of deferred financing costs (e)

 

—

 

 

 

—

 

 

 

0.01

 

 

 

0.01

 

ERP and CRM implementation expenses (f)

 

—

 

 

 

0.02

 

 

 

0.02

 

 

 

0.07

 

Other (g)

 

—

 

 

 

0.02

 

 

 

0.04

 

 

 

0.07

 

Tax effects (h)

 

(0.01

)

 

 

(0.04

)

 

 

(0.12

)

 

 

(0.09

)

Adjusted Diluted EPS

$

0.30

 

 

$

0.13

 

 

$

1.01

 

 

$

0.65

 

 

 

 

 

 

 

 

 

Weighted average diluted shares outstanding

 

80,064

 

 

 

81,195

 

 

 

80,718

 

 

 

80,170

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted SG&A to SG&A

 

Three Months Ended

 

Nine Months Ended

In thousands

October 3, 2026

 

September 27, 2025

 

October 3, 2026

 

September 27, 2025

SG&A

$

247,134

 

 

$

252,339

 

 

$

746,658

 

 

$

755,038

 

Stock-based compensation expense (a)

 

5,913

 

 

 

5,501

 

 

 

19,301

 

 

 

17,836

 

Litigation settlement (c)

 

—

 

 

 

1,903

 

 

 

—

 

 

 

1,903

 

ERP and CRM implementation expenses (f)

 

336

 

 

 

1,368

 

 

 

1,262

 

 

 

5,529

 

Other (g)

 

(285

)

 

 

1,258

 

 

 

2,713

 

 

 

6,412

 

Adjusted SG&A

$

241,170

 

 

$

242,309

 

 

$

723,382

 

 

$

723,358

 

 

 

 

 

 

 

 

 

SG&A Percent of Net Revenue

 

48.4

%

 

 

51.8

%

 

 

48.1

%

 

 

50.9

%

Adjusted SG&A Percent of Net Revenue

 

47.2

%

 

 

49.7

%

 

 

46.6

%

 

 

48.7

%

Note: Percentages reflect line item as a percentage of total net revenue.

(a)

 

Non-cash charges related to stock-based compensation programs, which may vary from period to period depending on the timing of awards and performance vesting conditions.

(b)

 

Reflects write-off related to non-cash impairment charges of long-lived assets, primarily impairment of property and equipment related to the Eyeglass World lab restructuring initiative in the second quarter of 2026 and lease-related assets on closed or underperforming stores.

(c)

 

Expenses associated with settlement of certain litigation.

(d)

 

Amortization of the increase in carrying values of finite-lived intangible assets resulting from the application of purchase accounting following the acquisition of the Company by affiliates of KKR & Co. Inc.

(e)

 

Amortization of deferred financing costs and other non-cash charges related to our debt. We adjust for amortization of deferred financing costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share under U.S. GAAP.

(f)

 

Costs related to the Company’s ERP and CRM implementation.

(g)

 

Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS, Adjusted EBITDA and Adjusted SG&A), which are primarily related to severance and associate-related cost associated with organizational restructuring of $2.2 million for nine months ended October 3, 2026, and $0.8 million and $2.9 million for the three and nine months ended September 27, 2025, respectively, cost associated with EGW restructuring of $0.6 million for the nine months ended October 3, 2026, and shareholder activism costs of $2.1 million for the nine months ended September 27, 2025. Certain costs associated with the EGW lab optimization initiative are recognized in costs applicable to revenue, with the remainder recorded in SG&A.

(h)

 

Represents the income tax effect of the total adjustments at our combined statutory federal and state income tax rates, including tax expense (benefit) from stock-based compensation.

Reconciliation of Adjusted Comparable Store Sales Growth to Total Comparable Store Sales Growth

 

Comparable store sales growth (a)

 

Three Months Ended October 3, 2026

 

Three Months Ended September 27, 2025

 

Nine Months Ended October 3, 2026

 

Nine Months Ended September 27, 2025

 

2026 Outlook (b)

Owned & Host segment

 

 

 

 

 

 

 

 

 

America’s Best

3.4 %

 

8.1 %

 

3.5 %

 

6.7 %

 

 

Eyeglass World

(2.5) %

 

5.2 %

 

1.2 %

 

3.7 %

 

 

Military

1.9 %

 

4.4 %

 

0.5 %

 

3.4 %

 

 

Fred Meyer

3.2 %

 

4.1 %

 

0.1 %

 

4.1 %

 

 

 

 

 

 

 

 

 

 

 

 

Total comparable store sales growth

3.6 %

 

6.8 %

 

3.8 %

 

5.7 %

 

2.5% - 3.5%

Adjustments for effects of: (b)

 

 

 

 

 

 

 

 

 

Unearned & deferred revenue

(0.8) %

 

0.9 %

 

(0.6) %

 

0.7 %

 

(0.5) %

Adjusted Comparable Store Sales Growth

2.8 %

 

7.7 %

 

3.2 %

 

6.4 %

 

2.0% - 3.0%

(a)

 

We calculate total comparable store sales based on consolidated net revenue excluding the impact of (i) Corporate and other revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month (v) if applicable, the impact of a 53rd week in a fiscal year; and (vi) in fiscal years following a 53-week fiscal year, there is a one week calendar shift to the comparable prior-year period. For the calculation of the adjusted comparable store sales growth in the third quarter of 2026, we compared weeks 27 through 39 in fiscal 2026 against weeks 28 through 40 in fiscal 2025. Brand-level comparable store sales growth is calculated based on point-of-sale revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 15. “Segment Reporting” in our Annual Report on Form 10-K for the period ended January 3, 2026.

(b)

 

Adjusted Comparable Store Sales Growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in the changes from total comparable store sales growth based on consolidated net revenue.

 

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  267.44
+1.27 (0.48%)
AAPL  354.88
-0.75 (-0.21%)
AMD  585.30
+32.40 (5.86%)
BAC  50.51
-0.16 (-0.32%)
GOOG  295.35
+4.72 (1.62%)
META  623.61
-5.16 (-0.82%)
MSFT  523.00
+1.87 (0.36%)
NVDA  166.19
-7.54 (-4.34%)
ORCL  127.11
-1.27 (-0.99%)
TSLA  397.45
+6.61 (1.69%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.